Analogous Art Must Be Compared to the Challenged Patent | Knobbe Martens
In Sanofi-Aventis Deutschland GmbH v. Mylan Pharm. Inc., Case No. 2021-1981, the Federal Circuit reversed an obviousness determination by the PTAB. At issue was Sanofi’s reissued U.S....
Sanofi Aventis Deutschland Gmb Knobbe Martens Mylan Pharm Sanofi Aventis Deutschland Gmbh Federal Circuit Because Mylan
Source: jdsupra.com